Xiangfei Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiangfei Sun has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Kuntang Shen
Department of General Surgery, Zhongshan Hospital, Fudan University School of Medicine, Shanghai, China
37 shared publications - Chao Li
Department of General Surgery, Zhongshan Hospital, School of Medicine, Fudan University, Shanghai, China
36 shared publications - Hongshan Wang
Department of General Surgery, Zhongshan Hospital, Fudan University School of Medicine, Shanghai, China
36 shared publications - Tianhong Teng
Department of General Surgery
36 shared publications - Tuo Yi
Department of General Surgery, Zhongshan Hospital, Fudan University School of Medicine, Shanghai 200032, China
36 shared publications - Xiaodong Gao
Department of General Surgery, Zhongshan Hospital, Fudan University School of Medicine, Shanghai, China
36 shared publications
Latest Publications
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
Reanalysis of single-cell RNA sequencing (scRNA-seq)
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
Reanalysis of single-cell RNA sequencing (scRNA-seq)
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Table S8 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
Mass spectrometry analysis for anti-CCN2 immunoprecipitated samples
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S8 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
Mass spectrometry analysis for anti-CCN2 immunoprecipitated samples
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Table S7 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
Clinicopathological characteristics of 10 patients with GIST in TMT
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S7 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
Clinicopathological characteristics of 10 patients with GIST in TMT
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
CCN2 facilitates PGK1 mitochondrial translocation through interaction with Rack1 in GIST cells
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
CCN2 facilitates PGK1 mitochondrial translocation through interaction with Rack1 in GIST cells
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Table S5 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
Clinicopathologic information of 9 advanced gastrointestinal stromal tumor samples in GSE254762
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
Clinicopathologic information of 9 advanced gastrointestinal stromal tumor samples in GSE254762
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
TGF-β1–CCN2 signaling mediates CAF-induced imatinib resistance in GIST cells via paracrine regulation
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
TGF-β1–CCN2 signaling mediates CAF-induced imatinib resistance in GIST cells via paracrine regulation
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Table S6 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
Differentially expressed genes of the clusters
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
Differentially expressed genes of the clusters
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
Detailed information for antibody, primers and reagents
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
Detailed information for antibody, primers and reagents
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Table S9 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
Mass spectrometry analysis for anti-PGK1 immunoprecipitated samples
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S9 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
Mass spectrometry analysis for anti-PGK1 immunoprecipitated samples
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
PGK1 T302 phosphorylation regulates AKT-mTOR pathway activation
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming
PGK1 T302 phosphorylation regulates AKT-mTOR pathway activation